References
- A. D. B.: The Ketogenic Diet in Epilepsy. Can. Med. Assoc. J., 1931, 24: 106–107.
- Ahn W.K., Park S., Kim H.D.: Protein-Losing Enteropathy as a Complication of the Ketogenic Diet. Yonsei Med. J., 2017, 58: 891–893. doi: 10.3349/ymj.2017.58.4.891.
- Appavu B., Vanatta L., Condie J., Kerrigan J.F., Jarrar R.: Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure, 2016, 41: 62–65. doi: 10.1016/j.seizure.2016.07.006.
- Archer J., Warren A.E.L., Jackson G.D., Abbott D.: Conceptualizing Lennox-Gastaut syndrome as a secondary network epilepsy. Front. Neurol., 2014, 5: 225. doi: 10.3389/fneur.2014.00225.
- Arslan N., Guzel O., Kose E., Yılmaz U., Kuyum P., Aksoy B., Çalık T.: Is ketogenic diet treatment hepatotoxic for children with intractable epilepsy? Seizure, 2016, 43: 32–38. doi: 10.1016/j.seizure.2016.10.024.
- Arsov T., Mullen S.A., Damiano J.A., Lawrence K.M., Huh L.L., Nolan M. et al.: Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia, 2012a, 53: e204–e207. doi: 10.1111/epi.12007.
- Arsov T., Mullen S.A., Rogers S., Phillips A.M., Lawrence K.M., Damiano J.A. et al.: Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann. Neurol., 2012b, 72: 807–815. doi: 10.1002/ana.23702.
- Asadi-Pooya A.A.: Lennox-Gastaut syndrome: a comprehensive review. Neurol. Sci., 2018, 39: 403–414. doi: 10.1007/s10072-017-3188-y.
- Ashrafi M.R., Hosseini S.A., Zamani G.R., Mohammadi M., Tavassoli A., Badv R.S. et al: The efficacy of the ketogenic diet in infants and young children with refractory epilepsies using a formula-based powder. Acta Neurol. Belg., 2017, 117: 175–182. doi: 10.1007/s13760-016-0732-0.
- Azevedo de Lima P., Baldini Prudêncio M., Murakami D.K., Pereira de Brito Sampaio L., Figueiredo Neto A.M., Teixeira Damasceno N.R.: Effect of classic ketogenic diet treatment on lipoprotein subfractions in children and adolescents with refractory epilepsy. Nutrition, 2017, 33: 271–277. doi: 10.1016/j.nut.2016.06.016.
- Azevedo de Lima P., Pereira de Brito Sampaio L., Teixeira Damasceno N.R.: Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. Clinics (Sao Paulo), 2014, 69: 699–705. doi: 10.6061/clinics/2014(10)09.
- Ballaban-Gil K., Callahan C., O’Dell C., Pappo M., Moshé S., Shinnar S.: Complications of the ketogenic diet. Epilepsia, 1998, 39: 744–748.
- Barañano K.W., Hartman A.L.: The Ketogenic Diet: in Epilepsy and Other Neurologic Illnesses. Curr. Treat. Options Neurol., 2008, 10: 410–419.
- Bergqvist A.G.C.: Myoclonic astatic epilepsy and the use of the ketogenic diet. Epilepsy Res., 2012, 100: 258–260. doi:10.1016/j.epilepsyres.2011.04.009.
- Bergqvist A.G.C., Schall J.I., Gallagher P.R., Cnaan A., Stallings V.A.: Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia, 2005, 46: 1810–1819. doi: 10.1111/j.1528-1167.2005.00282.x.
- Bergqvist A.G.C., Schall J.I., Stallings V.A., Zemel B.S.: Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am. J. Clin. Nutr., 2008, 88: 1678–1684. doi: 10.3945/ajcn.2008.26099.
- Boison D.: New insights into the mechanism of the ketogenic diet. Curr. Opin. Neurol., 2017, 30: 187–192. doi: 10.1097/WCO.0000000000000432.
- Bough K.J., Wetherington J., Hassel B., Pare J.F., Gawryluk J.W., Greene J.G. et al: Mitochondrial Biogenesis in the Anticonvulsant Mechanism of the Ketogenic Diet. Ann. Neurol., 2006, 60: 223–235. doi: 10.1002/ana.20899.
- Bough K.J., Rho J.M.: Anitconvulsant Mechanism of the Ketogenic Diet. Epilepsia, 2007, 48: 43–58. doi: 10.1111/j.1528-1167.2007.00915.x.
- Bruce S., Devlin A., Air L., Cook L.: Changes in quality of life as a result of ketogenic diet therapy: A new approach to assessment with the potential for positive therapeutic effects. Epilepsy Behav., 2017, 66: 100–104. doi: 10.1016/j.yebeh.2016.10.001.
- Cai Q.Y., Zhou Z.J., Luo R., Gan J., Li S.P., Mu D.Z., Wan C.M.: Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J. Pediatr., 2017, 13: 528–536. doi: 10.1007/s12519-017-0053-2.
- Caraballo R.H.: Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet. Epilepsia, 2011, 52 (Suppl. 2): 79–82. doi: 10.1111/j.1528-1167.2011.03009.x.
- Caraballo R.H., Cersósimo R.O., Sakr D., Cresta A., Escobal N., Fejerman N.: Ketogenic diet in patients with Dravet syndrome. Epilepsia, 2005, 46: 1539–1544. doi: 10.1111/j.1528-1167.2005.05705.x.
- Caraballo R.H., Cersósimo R.O., Sakr D., Cresta A., Escobal N., Fejerman N.: Ketogenic diet in patients with myoclonicastatic epilepsy. Epileptic Disord., 2006, 8: 151–155.
- Caraballo R.H., Fortini S., Fresler S., Armeno M., Ariela A., Cresta A. et al.: Ketogenic diet in patients with Lennox-Gastaut syndrome. Seizure, 2014, 23: 751–755. doi: 10.1016/j.seizure.2014.06.005.
- Cervenka M.C., Henry B.J., Felton E.A., Patton K., Kossoff E.H.: Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges. Epilepsy Behav., 2016(a), 58: 61–68. doi: 10.1016/j.yebeh.2016.02.038.
- Cervenka M.C., Henry-Barron B.J., Kossoff E.H.: Is there a role for diet monotherapy in adult epilepsy? Epilepsy Behav. Case Rep., 2016(b), 7: 6–9. doi: 10.1016/j.ebcr.2016.09.005.
- Cervenka M.C., Kossoff E.H.: Dietary treatment of intractable epilepsy. Continuum (Minneap Minn), 2013, 19 (3 Epilepsy): 756–766. doi: 10.1212/01.CON.0000431396.23852.56.
- Cervenka M.C., Patton K., Eloyan A., Henry B., Kossoff E.H.: The impact of the modified Atkins diet on lipid profiles in adults with epilepsy. Nutr. Neurosci., 2016(c), 19: 131–137. doi: 10.1179/1476830514Y.0000000162.
- Chorągiewicz T., Żarnowska I., Gąsior M., Żarnowski T.: Przeciwdrgawkowe i neuroprotekcyjne działanie diety ketogennej. Przegl. Lek., 2010, 67: 205–212.
- Cross J.H., Auvin S., Falip M., Striano P., Arzimanoglou A.: Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations. Front. Neurol., 2017, 8: 505. doi: 10.3389/fneur.2017.00505.
- Cross J.H.: New research with diets and epilepsy. J. Child. Neurol., 2013, 28: 970–974. doi: 10.1177/0883073813487593.
- Curatolo P., Jóźwiak S., Nabbout R. on behalf of participants of the TSC Consensus Meeting for SEGA and Epilepsy Management.: Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur. J. Paediatr. Neurol., 2012, 16: 582–586. doi: 10.1016/j.ejpn.2012.05.004.
- Danial N.N., Hartman A.L., Stafstrom C.E., Thio L.L.: How does the ketogenic diet work? Four potential mechanisms. J. Child. Neurol., 2013, 28: 1027–1033. doi: 10.1177/0883073813487598
- Dressler A., Haiden N., Trimmel-Schwahofer P., Benninger F., Samueli S., Gröppel G. et al: Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy. Epilepsia Open, 2018, 3: 30–39. doi: 10.1002/epi4.12084.
- Dressler A., Trimmel-Schwahofer P., Reithofer E., Gröppel G., Mühlebner A., Samueli S. et al: The ketogenic diet in infants – Advantages of early use. Epilepsy Res., 2015(a), 116: 53–58. doi: 10.1016/j.eplepsyres.2015.06.015.
- Dressler A., Trimmel-Schwahofer P., Reithofer E., Mühlebner A., Gröppel G., Reiter-Fink E. et al.: Efficacy and tolerability of the ketogenic diet in Dravet syndrome – Comparison with various standard antiepileptic drug regimen. Epilepsy Res., 2015(b), 109: 81–89. doi: 10.1016/j.eplepsyres.2014.10.014.
- Dulac O., Takahashi T.: Status epilepticus. Handb. Clin. Neurol., 2013, 111: 681–689. doi: 10.1016/B978-0-444-528919.00070-1.
- Elamin M., Ruskin D.N., Masino S.A., Sacchettti P.: Ketone-based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism? Front. Mol. Neurosci., 2017, 10: 377. doi: 10.3389/fnmol.2017.00377.
- Elia M., Klepper J., Leiendecker B., Hartmann H.: Ketogenic diets in the treatment of epilepsy. Curr. Pharm. Des., 2017, 23: 5691–5701. doi: 10.2174/1381612823666170809101517.
- El-Rashidy O.F., Nassar M.F., Abdel-Hamid I.A., Shatla R.H., Abdel-Hamid M.H., Gabr S.S. et al.: Modified Atkins diet vs classic ketogenic formula in intractable epilepsy. Acta Neurol. Scand., 2013, 128: 402–408. doi: 10.1111/ane.12137.
- Eun S.H. Kang H.C., Kim D.W., Kim H.D.: Ketogenic diet for treatment of infantile spasms. Brain Dev., 2006, 28: 566–571. doi: 10.1016/j.braindev.2006.03.011.
- Farias-Moeller R., Bartolini L., Pasupuleti A., Cines R.D.B., Kao A., Carpenter J.L.: A practical Approach to Ketogenic Diet in the Pediatric Intensive Care Unit for Super-Refractory Status Epilepticus. Neurocrit Care, 2017, 26: 267–272. doi: 10.1007/s12028-016-0312-4.
- Fliciński J., Starczewska M., Steinborn B.: Wtórne niedobory i możliwości suplementacji L-karnityny w praktyce neurologa. Neurol. Dziec., 2016, 25: 29–38. doi: 10.20966/chn.2016.51.382.
- Freeman J.M., Vining E.P., Kossoff E.H., Pyzik P.L., Ye X., Goodman S.N.: A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia, 2009, 50: 322–325. doi: 10.1111/j.1528-1167.2008.01740.x.
- Freeman J.M., Vining E.P., Pillas D.J., Pyzik P.L., Casey J.C., Kelly M.T.: The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics, 1998, 102: 1358–1363. doi: 10.1542/peds.102.6.1358.
- French J.A., Koepp M., Naegelin Y., Vigevano F., Auvin S., Rho J.M. et al.: Clinical studies and anti-inflammatory mechanisms of treatments. Epilepsia, 2017 (Suppl. 58), 3: 69–82. doi: 10.1111/epi.13779.
- Gaspard N., Hirsch L.J., Sculier C., Loddenkemper T., van Baalen A., Lancrenon J. et al.: New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia, 2018, 59: 745–752. doi: 10.1111/epi.14022.
- Greco T., Glenn T.C., Hovda D.A., Prins M.L.: Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity. J. Cereb. Blood Flow Metab., 2016, 36: 1603–1613. doi: 10.1177/0271678X15610584.
- Groesbeck D.K., Bluml R.M., Kossoff E.H.: Long-term use of the ketogenic diet in the treatment of epilepsy. Dev. Med. Child. Neurol., 2006, 48: 978–981. doi: 10.1017/S0012162206002143.
- Groomes L.B., Pyzik P.L., Turner Z., Dorward J.L., Goode V.H., Kossoff E.H.: Do Patients With Absence Epilepsy Respond to Ketogenic Diets? J. Child. Neurol., 2011, 26: 160–165. doi: 10.1177/0883073810376443.
- Hallböök T., Lundgren J., Rosén I.: Ketogenic diet improves sleep quality in children with therapy-resistant epilepsy. Epilepsia, 2007, 48: 59–65.
- Hallböök T., Ji S., Maudsley S., Martin B.: The effects of the ketogenic diet on behavior and cognition. Epilepsy Res., 2012, 100: 304–309. doi: 10.1016/j.eplepsyres.2011.04.017.
- Hartman A.L., Vining E.P.G: Clinical Aspects of the Ketogenic Diet. Epilepsia, 2007, 48: 31–42. doi: 10.1111/j.1528-1167.2007.00914.x.
- Hemingway C., Freeman J.M., Pillas D.J., Pyzik P.L.: The ketogenic diet: a 3- to 6-year follow up of 150 children enrolled prospectively. Pediatrics, 2001, 108: 898–905.
- Henderson C.B., Filloux F.M., Alder S.C., Lyon J., Caplin D.A.: Efficacy of the Ketogenic Diet as a Treatment Option for Epilepsy: Meta-analysis. J. Child. Neurol., 2006, 21: 193–198.
- Heo G., Kim S.H., Chang M.J.: Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy. J. Clin. Pharm. Ther., 2017, 42: 758–764. doi: 10.1111/jcpt.12578.
- Hong A.M., Turner Z., Hamdy R.F., Kossoff E.H.: Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia, 2010, 51: 1403–1407.
- IJff D.M., Postulart D., Lambrechts D.A.J.E., Majoie M.H.J.M., de Kinderen R.J.A., Hendriksen J.G.M. et al.: Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trial. Epilepsy Behav., 2016, 60: 153–157. doi: 10.1016/j.yebeh.2016.04.033.
- Jung D.E., Kang H.C., Kim H.D.: Long-term outcome of the ketogenic diet for intractable childhood epilepsy with focal malformation of cortical development. Pediatrics, 2008, 122: e330–e333. doi: 10.1542/peds.2008-0012.
- Kang H.C., Chung D.E., Kim D.W., Kim H.D.: Early and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia, 2004, 45: 1116–1123. doi: 10.1111/j.0013-9580.2004.10004.x.
- Kang H.C., Lee Y.J., Lee J.S., Eom S.J., You S.J., Kim H.D.: Comparison of short-versus long-term ketogenic diet for intractable infantile spasm. Epilepsia, 2011, 52: 781–787.
- Kang H.C., Kim Y.J., Kim D.W., Kim H.D.: Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia, 2005, 46: 272–279. doi: 10.1111/j.0013-9580.2005.48504.x.
- Kayyali H.R., Gustafson M., Myers T., Thompson L., Williams M., Abdelmoity A.: Ketogenic diet efficacy in the treatment of intractable epileptic spasms. Pediatr. Neurol., 2014, 50: 224–227. doi: 10.1016/j.pediatrneurol.2013.11.021.
- Kayyali H.R., Luniova A., Abdelmoity A.: Ketogenic Diet decreases Emergency Room Visits and Hospitalizations Related to Epilepsy. Epilepsy Res. Treat., 2016: 5873208. doi: 10.1155/2016/5873208.
- Keene D.L.: A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr. Neurol., 2006, 35: 1–5. doi: 10.1016/j.pediatrneurol.2006.01.005.
- Kessler S.K., Gallagher P.R., Shellhaas R.A., Clancy R.R., Bergqvist A.G.: Early EEG improvement after ketogenic diet initiation. Epilepsy Res., 2011, 94: 94–101. doi: 10.1016/j.eplepsyres.2011.01.012.
- Kilaru S., Bergqvist A.G.C.: Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia, 2007, 48: 1703–1707. doi: 10.1111/j.1528-1167.2007.01186.x.
- Kim D.W., Kang H.C., Park J.C., Kim H.D.: Benefits of the nonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics, 2004, 114: 1627–1630. doi: 10.1542/peds.2004-1001.
- Kim J.A., Yoon J.R., Lee E.J., Lee J.S., Kim J.T., Kim H.D., Kang H.C.: Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia, 2016, 57: 51–58. doi: 10.1111/epi.13256.
- de Kinderen R.J., Lambrechts D.A., Postulart D., Kessels A.G., Hendriksen J.G., Aldenkamp A.P. et al.: Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: design of a randomized controlled trial. BMC Neurol., 2011, 11: 10.
- de Kinderen R.J., Lambrechts D.A., Wijnen B.F., Postulart D., Aldenkamp A.P., Majoie M.H., Evers S.M.: An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: An interim analysis. Epilepsia, 2016, 57: 41–50.
- de Kinderen R.J., Postulart D., Aldenkamp A.P., Evers S.M., Lambrechts D.A., Louw A.J. et al.: Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy. Epilepsy Res., 2015, 110: 119–131. doi: 10.1016/j.eplepsyres.2014.12.005.
- Kinsman S.L., Vining E.P., Quaskey S.A., Mellits D., Freeman J.M.: Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia, 1992, 33: 1132–1136.
- Klein P., Janousek J., Barber A., Weissberger R.: Ketogenic diet in adults with refractory epilepsy. Epilepsy Behav., 2010, 19: 575–579. doi: 10.1016/j.yebeh.2010.09.016.
- Klepper J., Leiendecker B., Bredhal R., Athanassopoulos S., Heinen, F., Gertsen E. et al: Introduction of a ketogenic diet in young infants. J. Inherit. Metab. Dis., 2002, 25: 449–460.
- Klepper J., Leiendecker B.: GLUT 1 deficiency syndrome-2007 update. Dev. Med. Child. Neurol., 2007, 49: 707–716. doi: 10.1111/j.1469-8749.2007.00707.x.
- Kose E., Guzel O., Arslan N.: Analysis of hematological parameters in patients treated with ketogenic diet due to drug-resistant epilepsy. Neurol. Sci., 2018, 39: 85–89. doi: 10.1007/s10072-017-3152-x.
- Kossoff E.H., Dorward J.L.: The Modified Atkins Diet. Epilepsia, 2008, 49 (Suppl. 8): 37–41. doi: 10.1111/j.1528-1167.2008.01831.x.
- Kossoff E.H., Hedderick E.F., Turner Z., Freeman J.M.: A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia, 2008a, 49: 1504–1509. doi: 10.1111/j.1528-1167.2008.01606.x.
- Kossoff E.H., Laux L.C., Blackford R., Morrison P.F., Pyzik P.L., Hamdy R.M. et al.: When do seizures usually improve with the ketogenic diet? Epilepsia, 2008b, 49: 329–333. doi: 10.1111/j.1528-1167.2007.01417.x.
- Kossoff E.H., Nabbout R.: Use of dietary therapy for status epilepticus. J. Child. Neurol., 2013, 28: 1049–1051. doi: 10.1177/0883073813487601.
- Kossoff E.H., Pyzik P.L., McGrogan J.R., Vining E.P., Freeman J.M.: Efficacy of the Ketogenic Diet for Infantile Spasms. Pediatrics, 2002, 109: 780–783. doi: 10.1542/peds.109.5.780.
- Kossoff E.H., Thiele E.A., Pfeifer H.H., McGrogan J.R., Freeman J.M.: Tuberous sclerosis complex and the ketogenic diet. Epilepsia, 2005, 46: 1684–1686. doi: 10.1111/j.1528-1167.2005.00266.x.
- Kossoff E.H., Turner Z., Bluml R.M., Pyzik P.L., Vining E.P.G.: A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav., 2007, 10: 432–436. doi: 10.1016/j.yebeh.2007.01.012.
- Kossoff E.H., Wang H.S.: Dietary therapies for epilepsy. Biomed. J., 2013, 36: 2–8. doi: 10.4103/2319-4170.107152.
- Kossoff E.H., Zupec-Kania B.A., Amark P.E., Ballaban-Gil K.R., Bergqvist C.A.G., Blackford R. et al.: Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia, 2009a, 50: 304–317. doi: 10.1111/j.1528-1167.2008.01765.x.
- Kossoff E.H., Zupec-Kania B.A., Rho J.M.: Ketogenic Diets: An Update for Child Neurologists. J. Child. Neurol., 2009b, 24: 979–988. doi: 10.1177/0883073809337162.
- Kramer U., Chi C.S., Lin K.L., Specchio N., Sahin M., Olson H. et al.: Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia, 2011, 52: 1956–1965. doi: 10.1111/j.1528-1167.2011.03250.x.
- Kwan P., Arzimanoglou A., Berg A.T., Brodie M. J., Hauser A.W., Mathern G. et al: Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 2010, 51: 1069–1077. doi: 10.1111/j.1528-1167.2009.02397.x.
- Lambrechts D.A., de Kinderen R.J., Vles J.S., de Louw A.J., Aldenkamp A.P., Majoie H.J.: A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol. Scand., 2017, 135: 231–239. doi: 10.1111/ane.12592.
- Lee J., Lee J.H., Yu H.J., Lee M.: Prognostic factors of infantile spasms: role of treatment options including a ketogenic diet. Brain Dev., 2013, 35: 821–826. doi: 10.1016/j.braindev.2013.06.014.
- Lee M.: The use of ketogenic diet in special situations: expanding use in intractable epilepsy and other neurologic disorders. Korean J. Pediatr., 2012, 55: 316–321. doi: 10.3345/kjp.2012.55.9.316.
- Lefevre F., Aronson N.: Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics, 2000, 105: E46.
- Lemmon M.E., Terao N.N., Ng Y.T., Reisig W., Rubenstein J.E., Kossoff E.H.: Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution’s experience and summary of the literature. Dev. Med. Child. Neurol., 2012, 54: 464–468. doi: 10.1111/j.1469-8749.2012.04233.x.
- Levy R., Cooper P.: Ketogenic diet for epilepsy. Cochrane Database Syst. Rev., 2003, 3: CD001903. doi: 10.1002/14651858.CD001903.
- Li B., Tong L., Jia G., Sun R.: Effects of ketogenic diet on the clinical and electroencephalographic features of children with drug therapy-resistant epilepsy. Exp. Ther. Med., 2013a, 5: 611–615. doi: 10.3892/etm.2012.823.
- Li H.F., Zou Y., Ding G.: Therapeutic Success of the Ketogenic Diet as a Treatment Option for Epilepsy: a Meta-analysis. Iran J. Pediatr., 2013b, 23: 613–620.
- Lin A., Turner Z., Doerrer S.C., Stanfield A., Kossoff E.H.: Complications During Ketogenic Diet Initiation: Prevalence, Treatment, and Influence on Seizure Outcomes. Pediatr. Neuro., 2017, 68: 35–39. doi: 10.1016/j.pediatrneurol.2017.01.007.
- Luat A.F., Coyle L., Kamat D.: The Ketogenic Diet: A Practical Guide for Pediatricians. Pediatr. Ann., 2016, 45: e446-e450. doi: 10.3928/19382359-20161109-01.
- Lyczkowski D.A., Pfeifer H.H., Ghosh S., Thiele E.A.: Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy. Epilepsia, 2005, 46: 1533–1538. doi: 10.1111/j.1528-1167.2005.22705.x.
- Maalouf M., Rho J.M., Mattson M.P.: The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Rev., 2009, 59: 293–315. doi: 10.1016/j.brainresrev.2008.09.002.
- Martin K., Jackson C.F., Levy R.G., Cooper P.N.: Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev., 2016, 2:CD001903. doi: 10.1002/14651858.CD001903.pub3.
- Martin-McGill K.J., Jenkinson M.D., Tudur Smith C., Marson A.G.: The modified ketogenic diet for adults with refractory epilepsy: An evaluation of a set up service. Seizure, 2017, 52: 1–6. doi: 10.1016/j.seizure.2017.08.013.
- Masino S.A., Rho J.M.: Mechanisms of Ketogenic Diet Action. In: J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (eds.), SourceJasper’s Basic Mechanisms of the Epilepsies [Internet]. 4th ed., Bethesda (MD): National Center for Biotechnology Information (US), 2012.
- Mastrangelo M.: Lennox-Gastaut Syndrome: A State of the Art Review. Neuropediatrics, 2017, 48: 143–151. doi: 10.1055/s-0037-1601324.
- McArtney R., Bailey A., Champion H.: What is a ketogenic diet and how does it affect the use of medicines? Arch. Dis. Child. Educ. Pract. Ed., 2017, 102: 194–199. doi: 10.1136/archdischild-2014-307000.
- McDaniel S.S., Rensing N.R., Thio L.L., Yamada K.A., Wong M.: The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia, 2011, 52: e7–e11. doi: 10.1111/j.1528-1167.2011.02981.
- McNally M.A., Pyzik P.L., Rubenstein J.E., Hamdy R.F., Kossoff E.H.: Empiric use of potassium citrate reduces kidney stone incidence with the ketogenic diet. Pediatrics, 2009, 124: e300–e304. doi: 10.1542/peds.2009-0217.
- Mc Tague A., Cross J.H.: Treatment of Epileptic Encephalopathies. CNS Drugs, 2013, 27: 175–184. doi: 10.1007/s40263-013-0041-6.
- Mohanraj R., Brodie M.J.: Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur. J. Neurol., 2006, 13: 277–282. doi: 10.1111/j.1468-1331.2006.01215.x.
- Moriyama K., Watanabe M., Yamada Y., Shiihara T.: Protein-losing enteropathy as a rare complication of the ketogenic diet. Pediatr. Neurol., 2015, 52: 526–528. doi: 10.1016/j.pediatrneurol.2015.01.009.
- Morrison P.F., Pyzik P.L., Hamdy R., Hartman A.L., Kossoff E.H.: The influence of concurrent anticonvulsants on the efficacy of the ketogenic diet. Epilepsia, 2009, 50: 1999–2001. doi: 10.1111/j.1528-1167.2009.02053.x.
- Mullen S.A., Marini C., Suls A., Mei D., Della Giustina E., Buti D. et al.: Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch. Neurol., 2011, 68: 1152–1155. doi:10.1001/archneurol.2011.102.
- Nabbout R., Camfield C.S., Andrade D.M., Arzimanoglou A., Chiron C., Cramer J.A. et al.: Treatment issues for children with epilepsy transitioning to adult care. Epilepsy Behav., 2017, 69: 153–160. doi: 10.1016/j.yebeh.2016.11.008.
- Nabbout R., Copioli C., Chipaux M., Chemaly N., Desguerre I., Dulac O., Chiron C.: Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study. Epilepsia, 2011, 52: e54–e57. doi: 10.1111/j.1528-1167.2011.03107.x.
- Nabbout R., Mazzuca M., Hubert P., Peudennier S., Allaire C., Flurin V. et al: Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia, 2010, 51: 2033–2037. doi: 10.1111/j.1528-1167.2010.02703.x.
- Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G. et al: The ketogenic diet for the treatment of childhood epilepsy: a randomized controlled trial. Lancet Neurol., 2008, 7: 500–506. doi: 10.1016/S1474-4422(08)70092-9.
- Newell C., Bomhof M.R., Reimer R.A., Hittel D.S., Rho J.M., Shearer J.: Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol. Autism, 2016, 7: 37. doi: 10.1186/s13229-016-0099-3.
- Nizamuddin J., Turner Z., Rubenstein J.E., Pyzik P.L., Kossoff E.H.: Management and Risk Factors for Dyslipidemia With the Ketogenic Diet. J. Child. Neurol., 2008, 23: 758–761. doi: 10.1177/0883073808318061.
- Nunes V.D., Sawyer L., Neilson J., Sarri G., Cross J.H.: Diagnosis and management of epilepsies in adults and children: summary of updated NICE guidance. BMJ, 2012, 344: e281. doi: 10.1136/bmj.e281.
- Nordli D.R. Jr, Kuroda M.M., Carroll J., Koenigsberger D.Y., Hirsch L.J., Bruner H.J. et al.: Experience with the ketogenic diet in infants. Pediatrics, 2001, 108: 129–133.
- Ozdemir R., Kucuk M., Guzel O., Karadeniz C., Yilmaz U., Mese T.: Does ketogenic diet have any negative effect on cardiac systolic and diastolic functions in children with intractable epilepsy?: One-year follow-up results. Brain Dev., 2016, 38: 842–847. doi: 10.1016/j.braindev.2016.03.009.
- Palmer S., Towne M.C., Pearl P.L., Pelletier R.C., Genetti C.A., Shi J. et al: SLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures. Pediatr. Neurol., 2016, 64: 77–79. doi: 10.1016/j.pediatrneurol.2016.07.012.
- Park S., Lee E.J, Eom S., Kang H.C., Lee J.S., Kim H.D.: Ketogenic Diet for the management of Epilepsy Associated with Tuberous Sclerosis Complex in Children. J. Epilepsy Res., 2017, 7: 45–49. doi: 10.14581/jer.17008.
- Pascal L., Caraballo R.H., De Giorgis V., Reyes J.G., Macasaet J.A., Masnada S. et al.: Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two-centre experience. Seizure, 2018, 57: 34–37. doi: 10.1016/j.seizure.2018.03.005.
- Patel A., Pyzik P.L., Turner Z., Rubenstein J.E., Kossoff E.H.: Long-term outcomes of children treated with the ketogenic diet in the past. Epilepsia, 2010, 51: 1277–1282. doi: 10.1111/j.1528-1167.2009.02488.x.
- Paul E., Conant K.D. Dunne I.E., Pfeifer H.H., Lyczkowski D.A., Linshaw M.A., Thiele E.A.: Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Res., 2010, 90: 151–156. doi: 10.1016/j.eplepsyres.2010.04.005.
- Pires M.E., Ilea A., Bourel E., Bellavoine V., Merdariu D., Berquin P., Auvin S.: Ketogenic diet for infantile spasms refractory to first-line treatments: an open prospective study. Epilepsy Res., 2013, 105: 189–194. doi: 10.1016/j.eplepsyres.2012.11.009.
- Prasad C., Rupar T., Prasad A.N.: Pyruvate dehydrogenase deficiency and epilepsy. Brain Dev., 2011, 33: 856–865. doi: 10.1016/j.braindev.2011.08.003.
- Prezioso G., Carlone G., Zaccara G., Verrotti A.: Efficacy of ketogenic diet for infantile spasms: A systematic review. Acta Neurol. Scand., 2018, 137: 4–11. doi: 10.1111/ane.12830.
- Pulsifer M.B., Gordon J.M., Brandt J., Vining E.P., Freeman J.M.: Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev. Med. Child. Neurol., 2001, 43: 301–306.
- Raju K.N., Gulati S., Kabra M., Agarwala A., Sharma S., Pandey R.M., Kalra V.: Efficacy of 4:1 (classic) versus 2,5:1 ketogenic ratio diets in refractory epilepsy in young children: a randomized open labeled study. Epilepsy Res., 2011, 96: 96–100. doi:10.1016/j.eplepsyres.2011.05.005.
- Rezaei S., Abdurahman A.A., Saghazadeh A., Badv R.S., Mahmoudi M.: Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescent with epilepsy: A systemic revive and meta-analysis. Nutr. Neurosci., 2017, 25:1–18. doi: 10.1080/1028415X.2017.1387721.
- Rho J.M., Stafstrom C.E.: The ketogenic diet: What has science taught us? Epilepsy Res., 2012, 100: 210–217. doi: 10.1016/j.eplepsyres.2011.05.021.
- Rogawski M.A., Löscher W., Rho J.M.: Mechanisms of Action of Antiseizure Drugs and Ketogenic Diet. Cold Spring Harb. Perspect Med., 2016, 6. pii: a022780. doi: 10.1101/cshperspect.a022780.
- Sampaio L.P.B., Takakura C., Manreza M.L.G.: The use of a formula-based ketogenic diet in children with refractory epilepsy. Arq. Neuropsiquiatr., 2017, 75: 234–237. doi: 10.1590/0004-282X20170028.
- Schoeler N.E., Cross J.H.: Ketogenic dietary therapies in adults with epilepsy: a practical guide. Pract. Neurol., 2016, 16: 208–214. doi: 10.1136/practneurol-2015-001288.
- Seo J.H., Lee Y.M., Lee J.S., Kang H.C., Kim H.D.: Efficacy and tolerability of the ketogenic diet according to lipid: nonlipid ratios-comparison of 3:1 with 4 :1 diet. Epilepsia, 2007, 48: 801–805. doi: 10.1111/j.1528-1167.2007.01025.x.
- Sharma S., Jain P.: The ketogenic diet and other dietary treatments for refractory epilepsy in children. Ann. Indian Acad. Neurol., 2014, 17: 253–258. doi: 10.4103/0972-2327.138471.
- Sharma S., Jain P., Gulati S., Sankhyan N., Agarwala A.: Use of the modified Atkins diet in Lennox Gastaut syndrome. J. Child Neurol., 2015, 30: 576–579. doi: 10.1177/0883073814527162.
- Sharma S., Sankhyan N., Gulati S., Agarwala A.: Use of the modified Atkins diet for treatment of refractory childhood epilepsy: A randomised controlled trial. Epilepsia, 2013, 54: 481–486. doi: 10.1111/epi.12069.
- Sofou K., Dahlin M., Hallböök T., Lindefeldt M., Viggedal G., Darin N.: Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes. J. Inherit. Metab. Dis., 2017, 40: 237–245. doi:10.1007/s10545-016-0011-5.
- Spilioti M., Pavlou E., Gogou M., Katsanika I., Papadopoulou-Alataki E., Grafakou O. et al.: Valproate effect on ketosis in children under ketogenic diet. Eur. J. Paediatr. Neurol., 2016, 20: 555–559. doi: 10.1016/j.ejpn.2016.04.003.
- Stafstrom C.E., Rho J.M.: The Ketogenic Diet as a Treatment Paradigm for diverse Neurological Disorders. Front. Pharmacol., 2012, 3: 59. doi: 10.3389/fphar.2012.00059.
- Steinborn B., Mazurkiewicz-Bełdzińska M., Winczewska-Wiktor A.: Padaczka i drgawki w różnych okresach życia dziecka. In: B. Steinborn: Neurologia Wieku Rozwojowego, PZWL, Warszawa 2017, 311–560.
- Stenger E., Schaeffer M., Cances C., Motte J., Auvin S., Ville D. et al.: Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study. Epilepsy Res., 2017, 131: 64–69. doi: 10.1016/j.eplepsyres.2017.02.005.
- Stevens C.E., Turner Z., Kossoff E.H.: Hepatic Dysfunction as a Complication of Combined Valproate and Ketogenic Diet. Pediatr. Neurol., 2016, 54: 82–84. doi: 10.1016/j.pediatrneurol.2015.10.006.
- Strzelczyk A., Reif P.S., Bauer S., Belke M., Oertel W.H., Knake S., Rosenow F.: Intravenous initiation and maintenance of ketogenic diet: proof of concept in super-refractory status epilepticus. Seizure, 2013, 22: 581–583. doi: 10.1016/j.seizure.2013.03.007.
- Takeoka M., Riviello J.J. Jr, Pfeifer H., Thiele E.A.: Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia, 2002, 43: 1072–1075.
- Thammongkol S., Vears D.F., Bicknell-Royle J., Nation J., Draffin K., Stewart K.G. et al.: Efficacy of the ketogenic diet: which epilepsies respond? Epilepsia, 2012, 53: e55–e59. doi: 10.1111/j.1528-1167.2011.03394.x.
- Thiele E.A.: Implications of dietary therapy into the 21st century: conclusion to special issue. J. Child. Neurol., 2013, 28: 1054–1055. doi: 10.1177/0883073813488827.
- Thouin A., Crompton D.E.: GLUT1 deficiency syndrome: Absence epilepsy and La Soupe du Jour. Pract. Neurol., 2016, 16: 50–52. doi: 10.1136/practneurol-2015-001194.
- Ułamek-Kozioł M., Pluta R., Bogucka-Kocka A., Czuczwar S.J.: To treat or not to treat drug-refractory epilepsy by the ketogenic diet? That is the question. Ann. Agric. Environ. Med., 2016, 23: 533–536. doi:10.5604/12321966.1226841.
- van Baalen A., Vezzani A., Häusler M., Kluger G.: Febrile Infection-Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis. Neuropediatrics, 2017, 48: 5–18. doi: 10.1055/s-0036-1597271.
- van der Louw E., van den Hurk D., Neal E., Leiendecker B., Fitzsimmon G., Dority L. et al.: Ketogenic diet guidelines for infants with refractory epilepsy. Eur. J. Paediatr. Neurol., 2016, 20: 798–809. doi: 10.1016/j.ejpn.2016.07.009.
- van der Louw E.J., Williams T.J., Henry-Barron B.J., Olieman J.F., Duvekot J.J., Vermeulen M.J. et al.: Ketogenic diet therapy for epilepsy during pregnancy: A case series. Seizure, 2017, 45: 198–201. doi: 10.1016/j.seizure.2016.12.019.
- Vezyroglou K., Cross J.H.: Target Treatment in Childhood Epilepsy Syndromes. Curr. Treat. Options Neurol., 2016, 18: 29. doi: 10.1007/s11940-016-0407-4.
- Vining E.P., Freeman J.M., Ballaban-Gil K., Camfield C.S., Camfield P.R., Holmes G.L. et al.: A multi-center study of the efficacy of the ketogenic diet. Arch. Neurol., 1998, 55: 1433–1437.
- Walczyk T., Wick J.Y.: The ketogenic diet: making a comeback. Consult. Pharm., 2017, 32: 388–396. doi: 10.4140/TCP.n.2017.388.
- Wang T.T., Zhou D.: Non-invasive treatment options for focal cortical dysplasia. Exp. Ther. Med., 2016, 11: 1537–1541. doi: 10.3892/etm.2016.3100.
- Wexler I.D., Hemalatha S.G., McConnell J., Buist N.R., Dahl H.H., Berry S.A. et al: Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Neurology, 1997, 49: 1655–1661.
- Wheless J.W.: History of the ketogenic diet. Epilepsia, 2008, 49 (Suppl. 8): 3–5. doi: 10.1111/j.1528-1167.2008.01821.x.
- Wijnen B.F.M., de Kinderen R.J.A., Lambrechts D.A.J.E., Postulart D., Aldenkamp A.P., Majoie M.H.J.M., Evers S.M.A.A.: Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy. Epilepsy Res., 2017, 132: 91–99. doi: 10.1016/j.eplepsyres.2017.03.002.
- Wilmshurst J.M., Gaillard W.D., Vinayan K.P., Tsuchida T.N., Plouin P., Van Bogaert P. et al.: Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia, 2015(a), 56: 1185–1197. doi: 10.1111/epi.13057.
- Wilmshurst J.M., Burman R., Gaillard W.D., Cross J.H.: Treatment of infants with epilepsy: Common practices around the world. Epilepsia, 2015(b), 56: 1033–1046. doi: 10.1111/epi.13003.
- Yoon J.R., Lee E.J., Kim H.D., Lee J.H., Kang H.C.: Polyunsaturated fatty acid-enriched diet therapy for a child with epilepsy. Brain Dev., 2014, 36: 163–166. doi: 10.1016/j.braindev.2013.01.017.
- Yoon J.R., Kim H.D., Kang H.C.: Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy. Korean J. Pediatr., 2013, 56: 327–331. doi: 10.3345/kjp.2013.56.8.327.
- Youngson N.A., Morris M.J., Ballard J.W.O.: The mechanisms mediating the antiepileptic effects of the ketogenic diet, and potential opportunities for improvement with metabolism-altering drugs. Seizure, 2017, 52: 15–19. doi: 10.1016/j.seizure.2017.09.005.
- Yuen A.W.C., Walcutt I.A., Sander J.W.: An acidosis-sparing ketogenic (ASK) diet to improve efficacy and reduce adverse effects in the treatment of refractory epilepsy. Epilepsy Behav., 2017, 74: 15–21. doi: 10.1016/j.yebeh.2017.05.032.
- Zamani G.R., Mohammadi M., Ashrafi M.R., Karimi P., Mahmoudi M., Badv R.S. et al.: The effects of classic ketogenic diet on serum lipid profile in children with refractory seizures. Acta Neurol. Belg., 2016, 116: 529–534. doi: 10.1007/s13760-016-0601-x.
- Zhang Y., Wang Y., Zhou Y., Zhang L., Yu L., Zhou S.: Therapeutic effects of the ketogenic diet in children with Lennox-Gastaut syndrome. Epilepsy Res., 2016, 128: 176–180. doi: 10.1016/j.eplepsyres.2016.11.003.
- Zhang Y., Xu J., Zhang Y., Yang W., Li B.: The Anticonvulsant Effects of Ketogenic Diet on Epileptic Seizures and Potential Mechanisms. Curr. Neuropharmacol., 2018, 16: 66–70. doi: 10.2174/1570159X15666170517153509.
- Zhu D., Wang M., Wang J., Yuan J., Niu G., Zhang G. et al: Ketogenic diet effects on neurobehavioral development of children with intractable epilepsy: A prospective study. Epilepsy Behav., 2016, 55: 87–91. doi: 10.1016/j.yebeh.2015.12.011.
- Zupec-Kania B., Neal E., Schultz R., Roan M.E., Turner Z., Welborn M.: An update on diets in clinical practice. J. Child. Neurol., 2013, 28: 1015–1026. doi: 10.1177/0883073813487597.